Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents | Zendy

Lorenz Räber | Zendy; Lea Wohlwend | Zendy; Mathias Wigger | Zendy; Mario Togni | Zendy; Simon Wandel | Zendy; Peter Wenaweser | Zendy; Stéphane Cook | Zendy; Aris Moschovitis | Zendy; Rolf Vogel | Zendy; Bindu Kalesan | Zendy; Christian Seiler | Zendy; Franz R. Eberli | Zendy; Thomas F. Lüscher | Zendy; Bernhard Meier | Zendy; Peter Jüni | Zendy; Stephan Windecker | Zendy

Open Access

Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents

Author(s) -

Lorenz Räber,

Lea Wohlwend,

Mathias Wigger,

Mario Togni,

Simon Wandel,

Peter Wenaweser,

Stéphane Cook,

Aris Moschovitis,

Rolf Vogel,

Bindu Kalesan,

Christian Seiler,

Franz R. Eberli,

Thomas F. Lüscher,

Bernhard Meier,

Peter Jüni,

Stephan Windecker

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.110.004762

Subject(s) - medicine , sirolimus , paclitaxel , randomized controlled trial , cardiology , chemotherapy

Long-term comparative data of first-generation drug-eluting stents are scarce. We investigated clinical and angiographic outcomes of sirolimus-eluting (SES) and paclitaxel-eluting stents (PES) at 5 years as part of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) LATE study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research